Lv1
20 积分 2025-03-20 加入
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
4小时前
已完结
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
5小时前
已关闭
A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
5小时前
已完结
Economic impact of ferric carboxymaltose in haemodialysis patients
11天前
已关闭
Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway
11天前
已完结
The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
14天前
已完结
Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England
14天前
已完结
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose
14天前
已完结
Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy
14天前
已完结
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
16天前
已完结
皖公网安备34019202002308
